Pesquisas alternativas:
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
drug dev » drug deal (Expandir a Pesquisa), drug diet (Expandir a Pesquisa), drug does (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
drug dev » drug deal (Expandir a Pesquisa), drug diet (Expandir a Pesquisa), drug does (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
1
Por Huang, Peixin, Lee, Mark W, Sadrerafi, Keivan, Heruth, Daniel P, Zhang, Li Q, Maulik, Dev, Ye, Shui Qing
Publicado no Drug Des Devel Ther (2017)
“... mortality, serum tumor necrosis factor α (TNFα) levels, pulmonary myeloperoxidase activity, alveolar injury...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
“...Identification of novel targets is a critical first step in the drug discovery and development...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Lam, Fred C, Vu-Han, Tu-Lan, Van de Kooj, Bert, Kong, Yi Wen, Bandopadhayay, Pratiti, Beroukhim, Rameen, Sarkaria, Jann, Hammond, Paula, Yaffe, Michael
Publicado no Neuro Oncol (2019)
“... of the DNA damage response in cells that allows for the discovery of novel higher order synergistic drug...”Publicado no Neuro Oncol (2019)
Obter o texto integral
Obter o texto integral
Artigo
4
“... pharmacokinetics and pharmacodynamics, and they frequently interact with food and other drugs, requiring...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por van Rijn, Richard M., Harvey, Jessica H., Brissett, Daniela I., DeFriel, Julia N., Whistler, Jennifer L.
Publicado em 2013
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... for decades or less-intensive hypomethylating therapy. The year 2017, however, witnessed US Food and Drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
“... is one of the limitations. There are significant developments in drug delivery methods and there is a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Heredia, Alonso, Latinovic, Olga S, Barbault, Florent, de Leeuw, Erik PH
Publicado no Drug Des Devel Ther (2015)
“... options due to HIV-1 resistance, side effects, or drug costs. Further, it is likely that current drugs...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Chism, David D., De Silva, Dinuka, Whang, Young E.
Publicado no Expert Rev Anticancer Ther (2014)
“... receptors such as glucocorticoid receptor may substitute for androgen receptor. Drugs with novel mechanisms...”Publicado no Expert Rev Anticancer Ther (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Petta, Ioanna, Lievens, Sam, Libert, Claude, Tavernier, Jan, De Bosscher, Karolien
Publicado no Mol Ther (2016)
“... to investigate the unexplored potential of PPIs in drug discovery is driven by the need to find novel therapeutic...”Publicado no Mol Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“... by the pineal gland and enterochromaffin cells which control sleep and gastrointestinal motility. Low levels...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Berardi, Rossana, Santoni, Matteo, Morgese, Francesca, Ballatore, Zelmira, Savini, Agnese, Onofri, Azzurra, Mazzanti, Paola, Pistelli, Mirco, Pierantoni, Chiara, De Lisa, Mariagrazia, Caramanti, Miriam, Pagliaretta, Silvia, Pellei, Chiara, Cascinu, Stefano
Publicado em 2013
“...://www.clinicaltrials.gov), aimed to evaluate the efficacy and toxicity of combined approaches and to develop novel...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Wang, Xue Yan, Lim-Jurado, Margaret, Prepageran, Narayanan, Tantilipikorn, Pongsakorn, Wang, De Yun
Publicado no Ther Clin Risk Manag (2016)
“... on patients’ quality of life. Bilastine, a novel new-generation antihistamine that is highly selective...”Publicado no Ther Clin Risk Manag (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Renna, Antonio, Vejarano, L. Felipe, De la Cruz, Ernesto, Alió, Jorge L.
Publicado no Ophthalmol Ther (2016)
“...PURPOSE: The feasibility, in terms of safety and potential efficacy, of a new drug combination...”Publicado no Ophthalmol Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por de Leeuw, Erik PH
Publicado em 2014
“... compound that targets Lipid II is described that acts against multi-drug resistant isolates of A. baumannii...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Rossini, Maurizio, De Vita, Salvatore, Ferri, Clodoveo, Govoni, Marcello, Paolazzi, Giuseppe, Salvarani, Carlo, Adami, Silvano
Publicado em 2013
“... factor (TNF) administered monthly by subcutaneous injection. It is approved by the US Food and Drug...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Artigo
17
Por De Sensi, Francesco, De Potter, Tom, Cresti, Alberto, Severi, Silva, Breithardt, Günter
Publicado no Cardiovasc Diagn Ther (2015)
“... and their relevance for mechanism-based therapeutic strategies in this setting. Advances in risk stratification, drug...”Publicado no Cardiovasc Diagn Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Salzano, Giuseppina, Navarro, Gemma, Trivedi, Malav S., De Rosa, Giuseppe, Torchilin, Vladimir P.
Publicado no Mol Cancer Ther (2015)
“... novel type of non-toxic and easy-to-obtain nano-device for the combined therapy of siRNA and anti-cancer...”Publicado no Mol Cancer Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Ursini, Francesco, Russo, Emilio, De Giorgio, Roberto, De Sarro, Giovambattista, D’Angelo, Salvatore
Publicado no Ther Clin Risk Manag (2018)
“... with the different aspects of the disease, including traditional and biological disease-modifying antirheumatic drugs...”Publicado no Ther Clin Risk Manag (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20